论文部分内容阅读
杂交瘤(hybridoma)技术是1975年kohler和milstein在英国剑桥首先创立的,这一惊人的成就,使纯一抗体能在体外定向而大量的产生成为定论,该技术建立至今仅九年,在各国学者不懈的努力下,已形成一整套“杂交瘤技术”,该技术的发展方兴未艾,其推广、更新速度之迅猛,成果之显著,实为近代科学技术史所罕见。其应用范围涉及到生物学、医学、农牧学和生物工业等领域,为社会创造了巨额的经济
The hybridoma technique was first established in 1975 by kohler and milstein in Cambridge, England. This phenomenal achievement has led to the conclusion that purely antibody can be targeted in large quantities in vitro. This technology has been established for only nine years now. In all countries Under the unremitting efforts of scholars, a whole set of “hybridoma technology” has been formed. The development of this technology is in the ascendant. The promotion and renewal of the technology is rapid and the result is remarkable. It is rare in the history of modern science and technology. Its scope of application involves the fields of biology, medicine, agriculture, animal husbandry and bio-industry, creating a huge economy for the society